Related Experiment Video
Updated: Jun 12, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
Handheld ultrasound, B-natriuretic peptide for screening stage B heart failure
Kathy Hebert1, Ron Horswell, Paul Heidenreich
1Division of Cardiology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. khebert1@gmail.com
Insights
B-natriuretic peptide (BNP) and handheld echocardiography show promise for screening stage B heart failure in diabetic patients. BNP is a reliable, inexpensive tool that can help identify patients needing further imaging.
Area of Science:
- Cardiology
- Medical Diagnostics
- Biomarkers
Background:
- Stage B heart failure is a precursor to symptomatic disease, often undetected in its early stages.
- Diabetic populations are at increased risk for heart failure.
- Early screening and diagnosis are crucial for timely intervention and improved patient outcomes.
Purpose of the Study:
- To evaluate the accuracy and reliability of B-natriuretic peptide (BNP) levels and handheld echocardiography as a screening tool for stage B heart failure.
- To assess the correlation between BNP levels, ejection fraction, and diastolic dysfunction.
- To determine the interobserver reliability of handheld echocardiogram interpretation.
Main Methods:
- A prospective study involving 145 indigent diabetic patients.
- Measurement of B-natriuretic peptide (BNP) levels.
- Performance of handheld echocardiography for each participant.
Main Results:
- BNP levels showed a correlation with ejection fraction but not with diastolic dysfunction.
- The area under the receiver-operator characteristic curve was 0.77, indicating good diagnostic accuracy.
- Kappa statistics confirmed a perfect interobserver reliability (1.0) for handheld echocardiogram interpretation.
Conclusions:
- BNP can serve as a reliable and inexpensive screening tool for stage B heart failure in diabetic patients.
- Incorporating BNP testing into heart failure diagnostic algorithms can help identify patients who require further imaging studies like echocardiography.
- Handheld echocardiography demonstrates high interobserver reliability and represents a promising alternative screening method.
Objective:
To determine if B-natriuretic peptide (BNP), handheld ultrasound, and echo interpretation was an accurate and reliable screening for stage B heart failure.
Methods:
One hundred and forty-five indigent diabetic patients were prospectively enrolled, and their BNP levels were measured. Each patient underwent a handheld echo.
Results:
BNP was correlated with ejection fraction, but not with diastolic dysfunction. The area under the receiver-operator characteristic was 0.77. Kappa statistics for reliability in interpreting handheld echoes was 1.0.
Conclusions:
Results from this study suggested that BNP may be able to serve as a reliable screening tool for stage B heart failure in diabetic populations. Because BNP is an inexpensive blood test, it could be incorporated into the congestive heart failure diagnostic algorithm to determine which patients need imaging studies, namely echocardiography. Handheld echocardiography had interobserver reliability and is a promising alternative screening method.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Assessing Blood pressure using a doppler ultrasound
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
Heart Failure II: Pathophysiology
Imaging Studies II: Ultrasonography
Heart Failure VII: Nursing Interventions
Heart Failure IV: Classification and Diagnostic Evaluation